Drawing for NOVORIG

USPTO serial 90112581

NOVORIG

Reviewed by CopyMark Law Group

Reg. 7629143Status 700Registered
Filing date
Status date
Registration date
Dec 31, 2024
Examiner
ROSEN, BENJAMIN H
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NOVORIG?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey B. Sladkus, Esq.

Jeffrey B. Sladkus, Esq. The Sladkus Law Group1397 Carroll DriveAtlanta, GA 30318United States

Goods and services

ClassDescriptionStatusFirst use
001Proteomics analysis test kits comprising reagents for detecting, quantifying and characterizing antibody proteins in a biological sample for scientific research purposesACTIVE—
005Medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune diseases and infectionsACTIVE—
044Providing medical diagnostic and prognostic testing for cancer, autoimmune diseases and infections, and the medical analysis, evaluation, and reporting of test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratoriesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 31, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 31, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 12, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 12, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 23, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 1, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 22, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 22, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 20, 2024ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Aug 28, 2024GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 28, 2024GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 28, 2024CNSISUSPENSION INQUIRY WRITTEN—
Dec 8, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 8, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Dec 8, 2023CNSLSUSPENSION LETTER WRITTEN—
Dec 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 7, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 6, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 23, 2023GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Oct 23, 2023GNSIINQUIRY TO SUSPENSION E-MAILED—
Oct 23, 2023CNSISUSPENSION INQUIRY WRITTEN—
Oct 23, 2023DOCKASSIGNED TO EXAMINER—
Oct 17, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 13, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 13, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Mar 13, 2023CNSLSUSPENSION LETTER WRITTEN—
Mar 13, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 13, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 13, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 10, 2023ALIEASSIGNED TO LIE—
Mar 3, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 16, 2022GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Dec 16, 2022GNSIINQUIRY TO SUSPENSION E-MAILED—
Dec 16, 2022CNSISUSPENSION INQUIRY WRITTEN—
Jun 1, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 1, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Jun 1, 2022CNSLSUSPENSION LETTER WRITTEN—
Jun 1, 2022DMCCDATA MODIFICATION COMPLETED—
May 31, 2022DPCCDIVISIONAL PROCESSING COMPLETE—
May 31, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 3, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 3, 2022DRRRDIVISIONAL REQUEST RECEIVED—
May 3, 2022ERTDTEAS REQUEST TO DIVIDE RECEIVED—
May 3, 2022ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 5, 2021GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Nov 5, 2021GNSIINQUIRY TO SUSPENSION E-MAILED—
Nov 5, 2021CNSISUSPENSION INQUIRY WRITTEN—
May 5, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 5, 2021GNSLLETTER OF SUSPENSION E-MAILED—
May 5, 2021CNSLSUSPENSION LETTER WRITTEN—
Apr 12, 2021DOCKASSIGNED TO EXAMINER—
Mar 23, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 23, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 18, 2021ALIEASSIGNED TO LIE—
Dec 16, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 14, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 14, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 14, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 14, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 14, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 14, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 8, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2020DOCKASSIGNED TO EXAMINER—
Sep 17, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance